U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
LISOCABTAGENE MARALEUCEL
7K2YOJ14X0
Possibly Marketed Outside US
First approved in 2021
General
Names
7
Classification
11
Identifiers
7
Related Substances
1
LISOCABTAGENE MARALEUCEL
7K2YOJ14X0
Possibly Marketed Outside US
First approved in 2021
General
Approval Year
2021
460
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
BREYANZI
Preferred Name
English
LISOCABTAGENE MARALEUCEL
Official Name
English
JCAR-017
Code
English
JCAR017
Code
English
LISOCABTAGENE MARALEUCEL [USAN]
Common Name
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
11
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of diffuse large B-cell lymphoma
FDA ORPHAN DRUG
516115
Designated
ORPHAN DRUG
Designated
Treatment of splenic marginal zone lymphoma
FDA ORPHAN DRUG
933623
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of primary mediastinal large B-cell lymphoma
FDA ORPHAN DRUG
644018
Adoptive Cell Therapy Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Adoptive Cell Therapy Agent
[C142078]
Antineoplastic Immune Cell
NCI_THESAURUS
C129826
Designated/Approved
ORPHAN DRUG
Designated/Approved
Treatment of follicular lymphoma (FL)
FDA ORPHAN DRUG
600517
Showing 1 to 5 of 11 entries
Previous
1
2
3
Next
Identifiers
7
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
100000176403
PRIMARY
RXCUI
2479136
PRIMARY
INN
10805
PRIMARY
FDA UNII
7K2YOJ14X0
PRIMARY
DAILYMED
7K2YOJ14X0
PRIMARY
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Related Substances
1
ACTIVE MOIETY
7K2YOJ14X0
LISOCABTAGENE MARALEUCEL
